Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sector Perform Smith & Nephew (SN.) by RBC Capital
- Overweight Oxford Instruments (OXIG) by JP Morgan
- Underperform Vistry Group (VTY) by RBC Capital
- Avoid Beeks Financial Cloud Group (BKS) by Steve Moore in ShareProphets
- Buy Tesco (TSCO) by Deutsche Bank
- Sell BT Group (BT.A) by Deutsche Bank
- Buy Halfords Group (HFD) by Shore Capital
- Buy The Gym Group (GYM) by Deutsche Bank
- Hold Rio Tinto (RIO) by Jefferies
- Buy Glencore (GLEN) by Jefferies
- Buy Anglo American (AAL) by Jefferies
- Hold Antofagasta (ANTO) by Jefferies
- Buy South32 Limited (DI) (S32) by Jefferies
- Hold BHP Group Limited NPV (DI) (BHP) by Jefferies
- Buy British American Tobacco (BATS) by Jefferies
- Neutral British Land Company (BLND) by JP Morgan
- Overweight Big Yellow Group (BYG) by JP Morgan
- Overweight Workspace Group (WKP) by JP Morgan
- Buy Fevertree Drinks (FEVR) by Jefferies
- Neutral Sainsbury (J) (SBRY) by Citi
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,270 open tips for AstraZeneca (AZN)
| Latest Bid : 13,624.00p | Latest Ask : 13,628.00p |
| High Today : 13,730.00p | Low Today : 13,590.00p |
| This Years High : 15,316.00p | This Years Low : 10,120.00p |
| Volume : 104,864 | MKT Cap : £211234M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Deutsche Bank | Premium Only | 2026-06-02 11:00:00 02/06/2026 | -2.19% |
| Buy | Jefferies | Premium Only | 2026-05-13 12:46:00 13/05/2026 | -0.10% |
| Add | Simon Watkins | Premium Only | 2026-05-06 09:30:00 06/05/2026 | 0.46% |
| Outperform | Bernstein | Premium Only | 2026-05-04 06:05:00 04/05/2026 | 0.44% |
| Buy | DZ Bank | Premium Only | 2026-04-29 12:24:00 29/04/2026 | -0.82% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 13,624.00p | Latest Ask : 13,628.00p |
| High Today : 13,730.00p | Low Today : 13,590.00p |
| This Years High : 15,316.00p | This Years Low : 10,120.00p |
| Volume : 104,864 | MKT Cap : £211234M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Deutsche Bank | Premium Only | 2026-06-02 11:00:00 02/06/2026 | -2.19% |
| Buy | Jefferies | Premium Only | 2026-05-13 12:46:00 13/05/2026 | -0.10% |
| Add | Simon Watkins | Premium Only | 2026-05-06 09:30:00 06/05/2026 | 0.46% |
| Outperform | Bernstein | Premium Only | 2026-05-04 06:05:00 04/05/2026 | 0.44% |
| Buy | DZ Bank | Premium Only | 2026-04-29 12:24:00 29/04/2026 | -0.82% |